title: Limited survival of human preislet cells transplanted into diabetic renal transplant recipients after 15 months.
authors.affiliation: Hana Biologics, Inc., Alameda, California 94501.
authors.forename: A
authors.initials: A
authors.lastname: Brewin
authors.forename: F
authors.initials: F
authors.lastname: Voss
authors.forename: G
authors.initials: G
authors.lastname: Collins
authors.forename: W
authors.initials: W
authors.lastname: Bry
authors.forename: I
authors.initials: I
authors.lastname: Dawidson
authors.forename: E
authors.initials: E
authors.lastname: Spees
authors.forename: K
authors.initials: K
authors.lastname: Lafferty
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D005355:Fibrosis; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007515:Islets of Langerhans / Q000473:pathology; D016381:Islets of Langerhans Transplantation; D016030:Kidney Transplantation; D016042:Transplantation, Heterotopic